Cargando…

Evidence for adverse effects of cannabidiol (CBD) products and their non-conformity on the European food market – response to the European Industrial Hemp Association

An interesting and valuable discussion has arisen from our recent article (Lachenmeier et al., 2020) and we are pleased to have the opportunity to expand on the various points we made. Equally important, we wish to correct several important misunderstandings that were made by Kruse and Beitzke (2020...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lachenmeier, Dirk W., Walch, Stephan G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	F1000 Research Limited 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7542252/ https://www.ncbi.nlm.nih.gov/pubmed/33082934 http://dx.doi.org/10.12688/f1000research.26045.2

Ejemplares similares

Are adverse effects of cannabidiol (CBD) products caused by tetrahydrocannabinol (THC) contamination?
por: Lachenmeier, Dirk W., et al.
Publicado: (2023)

Bioactive Hemp Clothing Modified with Cannabidiol (CBD) Cannabis sativa L. Extract
por: Zimniewska, Malgorzata, et al.
Publicado: (2021)

Hair Regrowth with Cannabidiol (CBD)-rich Hemp Extract – A Case Series
por: Smith, Gregory L., et al.
Publicado: (2021)

A new Cannabis genome assembly associates elevated cannabidiol (CBD) with hemp introgressed into marijuana
por: Grassa, Christopher J., et al.
Publicado: (2021)

Conversion of Cannabidiol (CBD) into Psychotropic Cannabinoids Including Tetrahydrocannabinol (THC): A Controversy in the Scientific Literature
por: Golombek, Patricia, et al.
Publicado: (2020)

Time Trends of Tetrahydrocannabinol (THC) in a 2008–2021 German National Survey of Hemp Food Products
por: Dräger, Hannah, et al.
Publicado: (2022)

Cannabidiol (CBD) in Cancer Management
por: O’Brien, Kylie
Publicado: (2022)

Genomic and Chemical Diversity of Commercially Available High-CBD Industrial Hemp Accessions
por: Johnson, Matthew S., et al.
Publicado: (2021)

Industrial, CBD, and Wild Hemp: How Different Are Their Essential Oil Profile and Antimicrobial Activity?
por: Zheljazkov, Valtcho D., et al.
Publicado: (2020)

In vivo Evidence for Therapeutic Properties of Cannabidiol (CBD) for Alzheimer's Disease
por: Watt, Georgia, et al.
Publicado: (2017)

Towards Better Delivery of Cannabidiol (CBD)
por: Millar, Sophie Anne, et al.
Publicado: (2020)

Cannabidiol (CBD) and Insomnia : Literature review
por: Gutierrez Higueras, T., et al.
Publicado: (2022)

The use of cannabidiol (CBD) as an analgesic component
por: Petersen, Kristian Kjær-Staal, et al.
Publicado: (2023)

Hemp in Animal Diets—Cannabidiol
por: Fallahi, Sepideh, et al.
Publicado: (2022)

Inhibition of Nicotine Metabolism by Cannabidiol (CBD) and 7-Hydroxycannabidiol (7-OH-CBD)
por: Nasrin, Shamema, et al.
Publicado: (2023)

Cannabidiol (CBD) in Rheumatic Diseases (Musculoskeletal Pain)
por: Boehnke, Kevin F., et al.
Publicado: (2022)

The Anti-Inflammatory Effects of Cannabidiol (CBD) on Acne
por: Peyravian, Nadia, et al.
Publicado: (2022)

Dispensary Cannabidiol (CBD): Nothing to Worry About!
por: Elliott, Taylor, et al.
Publicado: (2023)

A protocol for the delivery of cannabidiol (CBD) and combined CBD and ∆(9)-tetrahydrocannabinol (THC) by vaporisation
por: Solowij, Nadia, et al.
Publicado: (2014)

Comment on Lachenmeier et al (2020) “Are side effects of cannabidiol (CBD) products caused by tetrahydrocannabinol (THC) contamination?”: disputation on various points in the publication
por: Kruse, Daniel, et al.
Publicado: (2020)

Alternative ground covers and strip-tilling in CBD hemp production
por: Osorio, Erika, et al.
Publicado: (2023)

Cannabidiol (CBD) as a Promising Anti-Cancer Drug
por: Seltzer, Emily S., et al.
Publicado: (2020)

Trends in Internet Searches for Cannabidiol (CBD) in the United States
por: Leas, Eric C., et al.
Publicado: (2019)

Therapeutic Potential of Cannabidiol (CBD) for Skin Health and Disorders
por: Baswan, Sudhir M, et al.
Publicado: (2020)

Mechanisms of Cannabidiol (CBD) in Cancer Treatment: A Review
por: Heider, Camren G., et al.
Publicado: (2022)

Potential Adverse Drug Events and Drug–Drug Interactions with Medical and Consumer Cannabidiol (CBD) Use
por: Brown, Joshua D., et al.
Publicado: (2019)

Toxicological safety assessment of HempChoice® hemp oil extract; a proprietary extract consisting of a high concentration of cannabidiol (CBD) in addition to other phytocannabinoids and terpenes derived from CannabissativaL
por: Dziwenka, Margitta, et al.
Publicado: (2023)

Industrial Hemp as a Potential Nonwood Source of Fibres for European Industrial-Scale Papermaking—A Review
por: Danielewicz, Dariusz
Publicado: (2023)

Self-reported Cannabidiol (CBD) Use for Conditions With Proven Therapies
por: Leas, Eric C., et al.
Publicado: (2020)

Cannabidiol (CBD) modulation of apelin in acute respiratory distress syndrome
por: Salles, Évila Lopes, et al.
Publicado: (2020)

Availability and Promotion of Cannabidiol (CBD) Products in Online Vape Shops
por: Leas, Eric C., et al.
Publicado: (2021)

Cannabidiol (CBD) Use among children with juvenile idiopathic arthritis
por: Failing, Christopher J, et al.
Publicado: (2021)

Impact of smoking cannabidiol (CBD)-rich marijuana on driving ability
por: Gelmi, Tim J., et al.
Publicado: (2021)

Cannabidiol (CBD) as a novel treatment in the early phases of psychosis
por: Chesney, Edward, et al.
Publicado: (2021)

Absence of Relevant Thermal Conversion of Cannabidiol to Tetrahydrocannabinol in E-Cigarette Vapor and Low-Tetrahydrocannabinol Cannabis Smoke
por: Hindelang, Pascal, et al.
Publicado: (2022)

A Multiple Correspondence Analysis of Patterns of CBD Use in Hemp and Marijuana Users
por: Vilches, Joseph R., et al.
Publicado: (2021)

American Horseflesh in European Food-markets
Publicado: (1895)

Cannabidiol Content and In Vitro Biological Activities of Commercial Cannabidiol Oils and Hemp Seed Oils
por: Kitamura, Masashi, et al.
Publicado: (2020)

17.4 POSSIBLE MECHANISMS INVOLVED IN THE ANTIPSYCHOTIC EFFECTS OF CANNABIDIOL (CBD)
por: Crippa, Jose Alexandre, et al.
Publicado: (2018)

Cannabidiol (CBD): a killer for inflammatory rheumatoid arthritis synovial fibroblasts
por: Lowin, Torsten, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6cb95uru5q620j9a1i68lpafr5